Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2019-02-17 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
ASX Lodgement Supplementary Prospectus 8 pages 1.0MB
Regulatory Filings
2019-02-17 English
GTG US and UK Research Collaboration 2 pages 587.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 1 February 2019 from Genetic Technologies Limited about entering into a research collaboration with medical centers. It describes the nature of the collaboration, the benefits to the company, and some background on the company and its products. There are no financial statements, no detailed financial performance data, no regulatory certifications, no voting results, no management changes, no earnings data, and no mention of report attachments or filings. The document is a corporate announcement about a research collaboration, which fits best under general regulatory announcements or miscellaneous filings that do not fit other categories. The document length is 4281 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the best classification is Regulatory Filings (RNS).
2019-01-31 English
Quarterly Update and 4C 9 pages 458.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2018'. It contains detailed operational and financial information for the quarter, including cash flow statements, activities highlights, product development updates, and capital facility details. The presence of substantive financial data such as consolidated cash flow statements and operational highlights for a specific quarter indicates this is a comprehensive interim financial report. The document is about 15,000 characters long, which is consistent with a full quarterly report rather than a brief announcement or certification. The Appendix 4C is a standard quarterly report format under ASX Listing Rules, confirming this is an Interim / Quarterly Report. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). Q2 2019
2019-01-29 English
GTG receives Nasdaq Deficiency Notice 2 pages 103.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 29 January 2019 from Genetic Technologies Limited regarding receipt of a Nasdaq deficiency notice. It details the Nasdaq listing rules related to minimum bid price requirements and the compliance timeline. The document is a regulatory announcement about the company's stock listing status and compliance with exchange rules. It does not contain financial statements, earnings data, or detailed report content. It is not a report itself but an announcement about a regulatory compliance issue related to stock listing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-01-28 English
Blockshine Health ASX Announcement 2 pages 107.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 20 December 2018 from Genetic Technologies Limited about entering a new biomedical blockchain joint venture. It contains no financial statements, no regulatory certifications, no voting results, no management changes, no earnings data, and no detailed report content. The document is a corporate announcement about a new business initiative and partnership. It is relatively short (4540 characters) and reads like a press release or announcement rather than a formal report or filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2018-12-20 English
End of Year R&D Update 2 pages 443.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 21 December 2018 from Genetic Technologies Limited providing an update on its R&D test development program progress and expected commercialization timelines. It discusses research collaborations, validation studies, and upcoming product availability but does not contain any financial statements, detailed financial results, or regulatory filings. The content is a corporate update on operational progress rather than a formal financial report or regulatory filing. It is not an earnings release, annual or interim report, or any other formal report type. The document is a general market announcement providing information to investors and the market about company developments. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2018-12-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.